American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders
Lead: Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders
Lead: Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders
Tuesday 6th August 2024
Explore how social vulnerability affects mental health and substance use disorders, plus trends in addiction treatment and barriers to care.
4 minutes
Informative
Educational
Supportive
Compassionate
Eye-opening
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
131 (View all)
Do you want to link to this podcast?
Get the buttons here!Social Vulnerability's Impact on Mental Health and Substance Use Disorders
Episode Overview
- Social vulnerability is linked to higher rates of mental health and substance use disorders.
- Treatment availability decreases in more socially vulnerable communities.
- Only 49% of patients received MOUD after injection-related infections.
- Community engagement helps reduce barriers to overdose education and naloxone distribution.
- Methamphetamine-related psychiatric hospitalisations have significantly increased.
Large increases in several mental health and substance use disorders and corresponding decreases in treatment were found in the most socially vulnerable communities
In this episode of 'This Week in Addiction Medicine', Zach Haruso brings you the latest research and news in the field of addiction medicine. The lead story examines a study from JAMA Psychiatry that investigates the link between social vulnerability and the prevalence of mental health and substance use disorders. With over 4,600 participants surveyed, the findings reveal significant increases in these disorders within the most socially vulnerable communities, alongside a troubling decrease in treatment availability.
This suggests that integrating social vulnerability measurements into care models could enhance support for those affected. The episode also highlights a retrospective study from JAMA Network Open focusing on medication for opioid use disorder (MOUD) after serious injection-related infections in Massachusetts. The study found that only 49% of patients received MOUD post-hospitalisation, with less than half continuing treatment over the following year. This points to a critical need for better strategies to initiate and retain treatment for this population.
Another notable discussion revolves around a study from Preventative Medicine, which evaluates the impact of community engagement on reducing perceived barriers to scaling up overdose education and naloxone distribution (OEND) and MOUD. The results show a significant reduction in these barriers, emphasising the importance of expanding access to these life-saving services. The episode also covers a case report from the Journal of Addiction Medicine about malignant catatonia in a patient with acute methamphetamine and cocaine intoxication.
The patient experienced severe psychotic symptoms and was treated with haloperidol and lorazepam. However, the report advises caution in using antipsychotics in such cases due to potential complications. Lastly, there's an analysis from Drug and Alcohol Dependence on U.S. trends in methamphetamine-involved psychiatric hospitalisations between 2015 and 2019. The study found a 68% increase in these admissions, contrasting with a decrease in opioid-related admissions. This trend underscores the growing challenge of methamphetamine use in the U.S.
If you're interested in understanding how social factors influence addiction or want to stay updated on the latest research, this episode is packed with valuable insights. Tune in for a deep dive into these critical issues affecting addiction medicine today.